Samrat Pharmachem Limited (BOM:530125)
India
· Delayed Price · Currency is INR 211.50
+1.55 (0.74%)
At close: Apr 28, 2026
Samrat Pharmachem Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | - | 0.48 | 96.68 | 118.62 | 147.05 | 25.06 | Upgrade
|
| Short-Term Investments | - | 3.6 | 0.11 | 0.14 | 0.1 | 0.01 | Upgrade
|
| Cash & Short-Term Investments | 193.65 | 4.08 | 96.78 | 118.76 | 147.15 | 25.07 | Upgrade
|
| Cash Growth | 169.27% | -95.78% | -18.50% | -19.29% | 487.00% | 113.73% | Upgrade
|
| Accounts Receivable | - | 565.36 | 692.78 | 516.75 | 435.75 | 330.05 | Upgrade
|
| Other Receivables | - | 0.18 | 0.2 | 0.18 | 0.31 | 3.18 | Upgrade
|
| Receivables | - | 565.54 | 692.97 | 516.93 | 436.2 | 333.41 | Upgrade
|
| Inventory | - | 380.05 | 206.77 | 325.28 | 124.16 | 114 | Upgrade
|
| Prepaid Expenses | - | 1.69 | 0.49 | 0.4 | 0.17 | 0.23 | Upgrade
|
| Other Current Assets | - | 82.25 | 28.66 | 29.17 | 4.93 | 0.54 | Upgrade
|
| Total Current Assets | - | 1,034 | 1,026 | 990.53 | 712.61 | 473.24 | Upgrade
|
| Property, Plant & Equipment | - | 104.65 | 107.16 | 106.95 | 99.77 | 93.94 | Upgrade
|
| Long-Term Investments | - | 69.02 | 69.78 | 59.26 | 25.63 | - | Upgrade
|
| Other Intangible Assets | - | 0.15 | 0.07 | 0.08 | 0.09 | 0.09 | Upgrade
|
| Other Long-Term Assets | - | 4.79 | 11.83 | 6.65 | 5.97 | 4.65 | Upgrade
|
| Total Assets | - | 1,215 | 1,217 | 1,166 | 846.12 | 573.97 | Upgrade
|
| Accounts Payable | - | 385.62 | 476.68 | 318.8 | 233.92 | 176.49 | Upgrade
|
| Accrued Expenses | - | 0.76 | 1.21 | 0.49 | 8.9 | 1.84 | Upgrade
|
| Short-Term Debt | - | 99.15 | 84.55 | 186.59 | 75.2 | 87.94 | Upgrade
|
| Current Income Taxes Payable | - | 9.41 | - | 21.35 | 55.28 | 6.75 | Upgrade
|
| Other Current Liabilities | - | 0.89 | 1.59 | 4.67 | - | 0.26 | Upgrade
|
| Total Current Liabilities | - | 495.83 | 564.03 | 531.91 | 373.29 | 273.27 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | 1.11 | 3.36 | 2.54 | 4.61 | 4.33 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | - | -0 | Upgrade
|
| Total Liabilities | - | 496.94 | 567.39 | 534.45 | 377.9 | 277.6 | Upgrade
|
| Common Stock | - | 30.9 | 30.9 | 30.9 | 30.9 | 30.9 | Upgrade
|
| Retained Earnings | - | - | - | 600.54 | 437.32 | 265.47 | Upgrade
|
| Comprehensive Income & Other | - | 687.11 | 619.07 | - | - | - | Upgrade
|
| Shareholders' Equity | 706.75 | 718 | 649.97 | 631.43 | 468.22 | 296.37 | Upgrade
|
| Total Liabilities & Equity | - | 1,215 | 1,217 | 1,166 | 846.12 | 573.97 | Upgrade
|
| Total Debt | 109.49 | 99.15 | 84.55 | 186.59 | 75.2 | 87.94 | Upgrade
|
| Net Cash (Debt) | 84.16 | -95.07 | 12.24 | -67.83 | 71.95 | -62.87 | Upgrade
|
| Net Cash Per Share | 27.25 | -30.77 | 3.96 | -21.95 | 23.29 | -20.35 | Upgrade
|
| Filing Date Shares Outstanding | 3.08 | 3.09 | 3.09 | 3.09 | 3.09 | 3.09 | Upgrade
|
| Total Common Shares Outstanding | 3.08 | 3.09 | 3.09 | 3.09 | 3.09 | 3.09 | Upgrade
|
| Working Capital | - | 537.78 | 461.65 | 458.62 | 339.32 | 199.97 | Upgrade
|
| Book Value Per Share | 228.64 | 232.39 | 210.37 | 204.37 | 151.54 | 95.92 | Upgrade
|
| Tangible Book Value | 706.62 | 717.86 | 649.9 | 631.36 | 468.13 | 296.28 | Upgrade
|
| Tangible Book Value Per Share | 228.60 | 232.34 | 210.35 | 204.34 | 151.51 | 95.89 | Upgrade
|
| Land | - | 0.89 | 0.89 | 0.89 | 0.89 | 0.89 | Upgrade
|
| Buildings | - | 63.29 | 63.29 | 63.29 | 63.29 | 63.16 | Upgrade
|
| Machinery | - | 103.34 | 101.1 | 97.46 | 83.86 | 75.11 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.